What does the USPSTF strongly recommend for pregnant women regarding hepatitis B?

The U.S. Preventive Services Task Force (USPSTF) strongly recommends screening for hepatitis B virus infection in pregnant women because this approach significantly reduces the risk of mother-to-child transmission of the virus. Detecting hepatitis B early enables healthcare providers to implement interventions such as antiviral therapy, which can lower the viral load and, in turn, minimize the risk of transmission during childbirth. This screening is crucial since many women with hepatitis B may be asymptomatic but still capable of transmitting the virus to their infants.

While assessing immunization records, providing education on liver health, and referral to specialists may all play important roles in overall care for pregnant women, they do not specifically address the immediate and critical need to identify and manage hepatitis B infection during pregnancy. The clear focus on screening underscores the importance of early detection and intervention in protecting both maternal and infant health.